Disrupting Insulin and IGF Receptor Function in Cancer

by Jingran Cao, Douglas Yee
Published 2021-01-01

Revisiting the IGF-1R as a breast cancer target

by Roudy Chiminch Ekyalongo, Douglas Yee
Published 2017-05-01

STAT6 Mediates Interleukin-4 Growth Inhibition in Human Breast Cancer Cells

by Jennifer L. Gooch, Barbara Christy, Douglas Yee
Published 2002-01-01

Yin Yang gene expression ratio signature for lung cancer prognosis.

by Wayne Xu, Shantanu Banerji, James R Davie, Fekadu Kassie, Douglas Yee, Robert Kratzke
Published 2013-01-01

Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells

by Aleksandra M. Ochnik, Mark S. Peterson, Svetlana V. Avdulov, Annabell S. Oh, Peter B. Bitterman, Douglas Yee
Published 2016-02-01

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

by Nathan A. Ungerleider, Sonia G. Rao, Ashkan Shahbandi, Douglas Yee, Tianhua Niu, Wesley D. Frey, James G. Jackson
Published 2018-10-01

The influence of therapeutic radiation on the patterns of bone marrow in ovary-intact and ovariectomized mice.

by Susanta K Hui, Leslie Sharkey, Louis S Kidder, Yan Zhang, Greg Fairchild, Kayti Coghill, Cory J Xian, Douglas Yee
Published 2012-01-01

Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.

by Marc A Becker, Yasir H Ibrahim, Annabell S Oh, Dedra H Fagan, Sara A Byron, Aaron L Sarver, Adrian V Lee, Leslie M Shaw, Cheng Fan, Charles M Perou, Douglas Yee
Published 2016-01-01

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.

by Xin Huang, Haein Park, Joseph Greene, James Pao, Erin Mulvey, Sophia X Zhou, Catherine M Albert, Fred Moy, Deepali Sachdev, Douglas Yee, Christoph Rader, Carl V Hamby, David M Loeb, Mitchell S Cairo, Xianzheng Zhou
Published 2015-01-01

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors

by Imke H. Bartelink, Brendan Prideaux, Gregor Krings, Lisa Wilmes, Pei Rong Evelyn Lee, Pan Bo, Byron Hann, Jean-Philippe Coppé, Diane Heditsian, Lamorna Swigart-Brown, Ella F. Jones, Sergey Magnitsky, Ron J Keizer, Niels de Vries, Hilde Rosing, Nela Pawlowska, Scott Thomas, Mallika Dhawan, Rahul Aggarwal, Pamela N. Munster, Laura J. Esserman, Weiming Ruan, Alan H. B. Wu, Douglas Yee, Véronique Dartois, Radojka M. Savic, Denise M. Wolf, Laura van ’t Veer
Published 2017-09-01

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

by Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara B. Haley, Anthony D. Elias, Judy C. Boughey, Kathleen Kemmer, Rachel L. Yung, Paula R. Pohlmann, Debu Tripathy, Amy S. Clark, Hyo S. Han, Rita Nanda, Qamar J. Khan, Kristen K. Edmiston, Emanuel F. Petricoin, Erica Stringer-Reasor, Carla I. Falkson, Melanie Majure, Rita A. Mukhtar, Teresa L. Helsten, Stacy L. Moulder, Patricia A. Robinson, Julia D. Wulfkuhle, Lamorna Brown-Swigart, Meredith Buxton, Julia L. Clennell, Melissa Paoloni, Ashish Sanil, Scott Berry, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Adam L. Asare, Jeffrey B. Matthews, Nola M. Hylton, Angela DeMichele, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van‘t Veer, Donald A. Berry, Laura J. Esserman
Published 2021-10-01